Bradykinin antagonists HOE-140 and CP-0597 diminish microcirculatory injury after ischaemia-reperfusion of the pancreas in rats

British Journal of Surgery

Volumn 83, Issue 2, 1996, Pages 189-195

  Hoffmann, T F ^a   Leiderer, R ^a   Waldner, H ^a   Messmer, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ ANTAGONIST; CP 0597; ICATIBANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLUORESCENCE MICROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICROCIRCULATION; NONHUMAN; PANCREAS ISCHEMIA; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SURGICAL TECHNIQUE;

ANIMALS; BRADYKININ; MALE; MICROCIRCULATION; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, BRADYKININ; REPERFUSION INJURY;

EID: 0030031302     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Iwatsuki K, Homma T, Malik KU. Permissive role of prostaglandins in the action of bradykinin on the pancreas of anesthetized dogs. J Pharmacol Exp Ther 1985; 233: 700-6.
2. Ryan JW, Moffat JG, Thompson AG. Role of bradykinin in the development of acute pancreatitis. Nature 1964; 204: 1212-13.
3. Ryan JW, Moffat JG, Thompson AG. Role of bradykinin system in acute hemorrhagic pancreatitis. Arch Surg 1965; 91: 14-24.
4. Yotsumoto F, Manabe T, Ohshio G. Bradykinin involvement in the aggravation of acute pancreatitis in rabbits. Digestion 1993; 54: 224-30.
5. Elliott DF, Horton EW, Lewis GP. Actions of pure bradykinin. J Physiol 1960; 153: 473-80.
6. Tsiotos GG, Mullany CJ, Zietlow S, van Heerden JA. Abdominal complications following cardiac surgery. Am J Surg 1994; 167: 553-7.
7. Gmaz-Nikulin E, Nikulin A, Plamenac P, Hegewald G, Gaon D. Pancreatic lesions in shock and their significance. J Pathol 1981; 135: 223-36.
8. Fernandez del Castillo C, Harringer W, Warshaw AL et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325: 382-7.
9. Blackstone MO. Acinar-cell or interstitial space: where is pancreatitis initiated? N Engl J Med 1987; 317: 319-20 (Letter).
10. Kusterer K, Poschmann T, Friedemann A, Enghofer M, Zendler S, Usadel KH. Arterial constriction, ischemia-reperfusion, and leukocyte adherence in acute pancreatitis. Am J Physiol 1993; 265: G165-71.
11. Broe PJ, Zuidema GD, Cameron JL. The role of ischemia in acute pancreatitis: studies with an isolated perfused canine pancreas. Surgery 1982; 91: 377-82.
12. Takahashi T, Yaginuma N. Ischemic injury of the human pancreas. Its basic patterns correlated with the pancreatic microvasculature. Pathol Res Pract 1985; 179: 645-51.
13. Redha F, Uhlschmid G, Ammann RW, Freiburghaus AU. Injection of microspheres into pancreatic arteries causes acute hemorrhagic pancreatitis in the rat: a new animal model. Pancreas 1990; 5: 188-93.
14. Bassi D, Kollias N, Fernandez del Castillo C, Foitzik T, Warshaw AL, Rattner DW, Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg 1994; 179: 257-63.
15. Longhurst JC, Dittman LE. Hypoxia, bradykinin, and prostaglandins stimulate ischemically sensitive visceral afferents. Am J Physiol 1987; 253: H556-67.
16. Hoffmann TF, Leiderer R, Waldner H, Arbogast S, Messmer K. Ischemia reperfusion of the pancreas: a new in vivo model for acute pancreatitis in rats. Res Exp Med 1995; 195: 125-44.
17. Schmid-Schoenbein GW, Zweifach BW, Kovalcheck S. The application of stereological principles to morphometry of the microcirculation in different tissues. Microvasc Res 1977; 14: 303-17.
18. Menger MD, Sack F-U, Barker JH, Feifel G, Messmer K. Quantitative analysis of microcirculatory disorders after prolonged ischemia in skeletal muscle. Therapeutic effects of prophylactic isovolemic hemodilution. Res Exp Med 1988; 188: 151-65.
19. Granger DN, Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994; 55: 662-75.
20. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of 'reflow-paradox'. Am J Physiol 1992; 263: H1901-6.
21. Grieshacher T, Lembeck F. Effects of the bradykinin antagonist, HOE 140, in experimental acute pancreatitis. Br J Pharmacol 1992; 107: 356-60.
22. Rocha e Silva M, Beraldo WT, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. Am J Physiol 1949; 156: 261-73.
23. Shimizu I, Wada S, Okahisa T et al. Radioimmunoreactive plasma bradykinin levels and histological changes during the course of cerulein-induced pancreatitis in rats. Pancreas 1993; 8: 220-5.
24. Ruud TE, Aasen AO, Kicrulf P, Stadaas J, Aune S. Studies on the plasma kallikrein-kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs. Scand J Gastroenterol 1985; 20: 877-82.
25. Popieraitis AS, Thompson AG. The site of bradykinin release in acute experimental pancreatitis. Arch Surg 1969; 98: 73-6.
26. Ofstad E. Formation and destruction of plasma kinins during experimental acute hemorrhagic pancreatitis in dogs. Scand J Gastroenterol Suppl 1970; 5: 1-44.
27. Ruud TE, Aasen AO, Kicrulf P, Stadaas J, Aune S. Studies on components of the plasma kallikrein-kinin system in peritoneal fluid and plasma before and during experimental acute pancreatitis in pigs. A preliminary report. Acta Chirurgica Scandinavica Supplementum 1982; 509: 89-91.
28. Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188; 197-201.
29. Messmer K, Sack FU, Menger MD, Bartlett R, Barker JH, Hammersen F. White cell-endothelium interaction during postischemic reperfusion of skin and skeletal muscle. In: Chien S, ed. Vascular Endothelium in Health and Disease (Advances in Experimental Medicine and Biology 242). New York: Plenum Press, 1988: 95-8.
30. Bradbury AW, Murie JA, Ruckley CV. Role of the leucocyte in the pathogenesis of vascular disease. Br J Surg 1993; 80: 1503-12.
31. Lehr HA, Guhlmann A, Nolte D, Keppler D, Messmer K. Leukotrienes as mediators in ischemia-reperfusion injury in a microcirculation model in the hamster. J Clin Invest 1991; 87: 2036-41.
32. Dahlen SE, Björk J, Hedqvist P et al. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci USA 1081; 78: 3887-01.
33. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 1992; 44: 1-80.
34. 9-bradykinin and other bradykinin fragments on the synthesis of prostacyclin and the binding of bradykinin by vascular cells in culture. Agents Actions 1988; 24: 224-31.
35. 2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br J Pharmacol 1989; 96: 920-6.
36. Kunze H, Vogt W. Significance of phospholipase A for prostaglandin formation. Ann N Y Acad Sci 1971; 180: 123-5.
37. Figueroa CD, Henderson LM, Kaufmann J et al. Immunovisualization of high (HK) and low (LK) molecular weight kininogens on isolated human neutrophils. Blood 1992; 79: 754-9.
38. Figueroa CD, MacIver AG, Bhoola KD. Identification of a tissue kallikrein in human polymorphonuclear leucocytes. Br J Haematol 1989; 72: 321-8.
39. Oyvin IA, Gaponyuk PY, Oyvin VI, Tokarev OY. The mechanism of blood vessel permeability derangement under the influence of histamine, scrotonin and bradykinin. Experientia 1970; 26: 843-4.
40. Mullins RJ, Hudgens RW. Increased skin lymph protein clearance after after arterial bradykinin infusion. Am J Physiol 1087; 253: H1462-9.